Skip to content

Sugammadex Versus Neostigmine Use in Patients Undergoing Septoplasty Operations

Phase IV Study of the Use of Sugammadex Versus Neostigmine in Septoplasty Operations

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02026999
Enrollment
88
Registered
2014-01-03
Start date
2012-01-31
Completion date
2013-02-28
Last updated
2014-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal Septum Deviation

Brief summary

The purpose of this study to determine the effectiveness of sugammadex in septoplasty patients whose mask ventilation would be difficult after extubation.

Detailed description

Patients undergoing septoplasty operation will be included to this study. After coming to operation room all the patients will have standard monitorisation and induction. After intubation they will have inhalational anesthesia as maintenance. According to the TOF (train of four) measurement all patient will have neuromuscular relaxant if needed. After the operation they will be extubated according to TOF or clinical parameters. And time for extubation, mask assistance need, any complication, mask difficulty, and time spent in postoperative care unit will be recorded. Then the results will be compared, whether sugammadex or neostigmine is better for these patients in means of extubation and postoperative status.

Interventions

None listed

Sponsors

Ankara University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

ASA (American Society of Anesthesiologist) I-II patients undergoing septoplasty operation

Exclusion criteria

* patient refusal * any allergy to any medication used

Design outcomes

Primary

MeasureTime frame
easy mask ventilation for septoplasty patientstime between end of surgery and extubation of the patient, approximately 5 to 10 minutes

Secondary

MeasureTime frame
Quick and safe transfer from postoperative care unittime spent in postanesthesia care unit approximately 10 to 60 minutes

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026